Methods and compositions for treating and preventing disease associated with alphaVbeta5 integrin

Details for Australian Patent Application No. 2012216372 (hide)

Owner The Regents of the University of California

Inventors Sheppard, Dean; Atakilit, Amha

Agent Spruson & Ferguson

Pub. Number AU-A-2012216372

Parent 2005229015

Filing date 22 August 2012

Wipo publication date 13 September 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 September 2012 Complete Application Filed

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216372

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216373-A method and device for treating a stiffened blood vessel

2012216371-Synthetic cornea from retinal stem cells